National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 68441 [2016-23874]

Download as PDF Federal Register / Vol. 81, No. 192 / Tuesday, October 4, 2016 / Notices Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Amir E. Zeituni, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 5601 Fishers Lane, MSC– 9834, Rockville, MD 20852, 301–496–2550, amir.zeituni@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: September 28, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–23874 Filed 10–3–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Dated: September 27, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [CBP Dec. No. 16–16] [FR Doc. 2016–23883 Filed 10–3–16; 8:45 am] AGENCY: U.S. Customs and Border Protection; Department of Homeland Security. ACTION: General notice. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting mstockstill on DSK3G9T082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Investigator Initiated Program Project Applications (P01) and NIAID Resource-Related Research Projects (R24). Date: November 10, 2016. Time: 9:30 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892, (Telephone Conference Call). Contact Person: Paul A. Amstad, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G41, NIAID/NIH/DHHS, 5601 Fishers Lane, Bethesda, MD 20892–7616, 240–669– 5067, pamstad@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, 19:01 Oct 03, 2016 Jkt 241001 Global Entry is a voluntary program that allows pre-approved participants dedicated U.S. Customs and Border Protection (CBP) processing into the United States using Global Entry kiosks located at designated airports. CBP previously announced in the Federal Register thirty-nine designated Global Entry airports. This document announces the expansion of the program to include nine additional designated Global Entry airports. DATES: Global Entry will be available at all nine airport locations on or before April 3, 2017. The exact starting date for each airport location will be announced on the CBP Global Entry Web site, https://www.globalentry.gov. FOR FURTHER INFORMATION CONTACT: Garret A. Conover, Office of Field Operations, (202) 325–4062, Garret.A.Conover@cbp.dhs.gov. SUPPLEMENTARY INFORMATION: SUMMARY: National Institutes of Health VerDate Sep<11>2014 Expansion of Global Entry to Nine Additional Airports Background Global Entry Program Global Entry is a voluntary program that allows for dedicated CBP processing of pre-approved travelers arriving in the United States at Global Entry kiosks located at designated airports. In a final rule published in the Federal Register (77 FR 5681) on February 6, 2012, CBP promulgated the regulation (8 CFR 235.12) to establish Global Entry as an ongoing voluntary regulatory program. Section 235.12 contains a description of the program, the eligibility criteria, the application and enrollment process, and redress procedures. Travelers who wish to participate in Global Entry must apply PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 68441 via the Global On-Line Enrollment System (GOES) Web site, https://goesapp.cbp.dhs.gov, and pay the applicable fee. Applications for Global Entry must be completed and submitted electronically. In the above-referenced final rule that established the Global Entry program, Global Entry was initially limited to twenty airports. The rule provides that any expansion of the Global Entry program to new airports will be by publication in the Federal Register and by posting the information at https:// www.globalentry.gov. See 8 CFR 235.12(c). In a notice published in the Federal Register (77 FR 17492) on March 26, 2012, Global Entry was expanded to include four additional designated airports. In a notice published in the Federal Register (78 FR 38069) on June 25, 2013, Global Entry was expanded to include eight additional designated airports. Finally, in a notice published in the Federal Register (80 FR 1510) on January 12, 2015, Global Entry was expanded to include an additional seven airports. The thirty-nine airports previously designated for Global Entry, listed alphabetically by state, and then city, include: • Ted Stevens Anchorage International Airport, Anchorage, Alaska (ANC); • Phoenix Sky Harbor International Airport, Phoenix, Arizona (PHX); • Los Angeles International Airport, Los Angeles, California (LAX); • San Diego International Airport, San Diego, California (SAN); • San Francisco International Airport, San Francisco, California (SFO); • John Wayne Airport, Santa Ana, California (SNA); • Denver International Airport, Denver, Colorado (DEN); • Ft. Lauderdale Hollywood International Airport, Fort Lauderdale, Florida (FLL), including the General Aviation Facility private aircraft terminal; • Miami International Airport, Miami, Florida (MIA); • Orlando International Airport, Orlando, Florida (MCO); • Sanford-Orlando International Airport, Sanford, Florida (SFB); • Tampa International Airport, Tampa, Florida (TPA); • Hartsfield-Jackson Atlanta International Airport, Atlanta, Georgia (ATL); • Honolulu International Airport, Honolulu, Hawaii (HNL); • Chicago Midway International Airport, Chicago, Illinois (MDW); • Chicago O’Hare International Airport, Chicago, Illinois (ORD); E:\FR\FM\04OCN1.SGM 04OCN1

Agencies

[Federal Register Volume 81, Number 192 (Tuesday, October 4, 2016)]
[Notices]
[Page 68441]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23874]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID Investigator Initiated Program 
Project Applications (P01) and NIAID Resource-Related Research 
Projects (R24).
    Date: November 10, 2016.
    Time: 9:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Paul A. Amstad, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3G41, NIAID/NIH/DHHS, 5601 Fishers Lane, Bethesda, 
MD 20892-7616, 240-669-5067, pamstad@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 28, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-23874 Filed 10-3-16; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.